3 ms·
But not particularly great compared to Covishield (Oxford-AZ) and Covaxin which are the main vaccines in use in India. The fancy needle free injector is almost
by unmole 5y ago
But not particularly great compared to Covishield (Oxford-AZ) and Covaxin which are the main vaccines in use in India. The fancy needle free injector is almost certainly going to be more expensive than a normal syringe and will make logistics more difficult. While the thermal stability is great, I don't think it will be a game changer. The one thing it has going for it is that it can be given to children above 12.
- throw3849 5y agoPerhaps it is easier to apply than injections. Rural India may not have qualified medical personnel.
- HelloNurse 5y agoNot qualified enough for intramuscular injections and paperwork? It doesn't seem likely. Fancy injectors might have advantages: less expensive, more expensive (in a corrupt enough setup), more compact, faster to use, physically or chemically better, but novelty itself makes them less easy to use.
- akrain 5y agoI couldn't find the effectiveness of Covishield against Delta but for Covaxin the claimed efficacy is in the same ballpark at 65%. So this is not bad at all. Ref: https://www.hindustantimes.com/india-news/covaxin-65-efficient-against-delta-variant-75-million-doses-supplied-so-far-bharat-biotech-101628789977213.html https://www.hindustantimes.com/india-news/covaxin-65-efficie...